|
SFRS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.595400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.543200E-01 |
| Normal-vs-Stage2 |
5.095600E-01 |
| Normal-vs-Stage3 |
4.390800E-01 |
| Normal-vs-Stage4 |
1.733800E-01 |
| Stage1-vs-Stage2 |
8.389700E-02 |
| Stage1-vs-Stage3 |
2.734300E-02 |
| Stage1-vs-Stage4 |
7.225000E-01 |
| Stage2-vs-Stage3 |
9.336600E-01 |
| Stage2-vs-Stage4 |
1.040390E-01 |
| Stage3-vs-Stage4 |
6.885900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.898600E-01 |
| Normal-vs-AfricanAmerican |
2.029400E-01 |
| Normal-vs-Asian |
2.162300E-02 |
| Caucasian-vs-AfricanAmerican |
2.769600E-01 |
| Caucasian-vs-Asian |
8.502200E-02 |
| AfricanAmerican-vs-Asian |
8.730000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.769000E-01 |
| Normal-vs-Female |
6.180800E-01 |
| Male-vs-Female |
4.394200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.344200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.506000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.900400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.251600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.510180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.759100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.219630E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.306220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.355700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.026000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.341800E-02 |
| Classical-VS-Follicular |
4.501900E-03 |
| Classical-VS-Other |
2.867000E-01 |
| Classical-VS-Normal |
5.275900E-02 |
| Tall-VS-Follicular |
9.793200E-01 |
| Tall-VS-Other |
1.438240E-02 |
| Tall-VS-Normal |
2.759800E-01 |
| Follicular-VS-Other |
8.014000E-02 |
| Follicular-VS-Normal |
2.727000E-01 |
| Other-VS-Normal |
3.341500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.986600E-01 |
| Normal-vs-N1 |
4.476600E-01 |
| N0-vs-N1 |
3.296800E-01 |
|
|
